Ficolins and the lectin pathway of complement in patients with systemic lupus erythematosus

Molecular Immunology

Volumn 63, Issue 2, 2015, Pages 209-214

  Hein, Estrid ^a   Nielsen, Louise Aas ^a   Nielsen, Christoffer T ^b,c   Munthe Fog, Lea ^a   Skjoedt, Mikkel Ole ^a   Jacobsen, Søren ^c   Garred, Peter ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b STATENS SERUM INSTITUT   (Denmark)

^c Rigshospitalet   (Denmark)

Author keywords

Arterial thrombosis; Complement; Ficolins; Lectin pathway; SLE; SLEDAI

Indexed keywords

BOVINE SERUM ALBUMIN; COMPLEMENT; EDETIC ACID; FICOLIN; FICOLIN 1; FICOLIN 2; FICOLIN 3; LECTIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; CLINICAL FEATURE; COMPLEMENT ACTIVATION; COMPLEMENT DEPOSITION; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NEPHRITIS; NEUTROPHIL COUNT; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; VEIN THROMBOSIS; BLOOD; CASE CONTROL STUDY; DEMOGRAPHY; IMMUNOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; YOUNG ADULT;

ADULT; AGED; CASE-CONTROL STUDIES; COMPLEMENT PATHWAY, MANNOSE-BINDING LECTIN; DEMOGRAPHY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LECTINS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; YOUNG ADULT;

EID: 84912046554     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.07.003     Document Type: Article

References (37)

1. Ammitzbøll C.G., Thiel S., Jensenius J.C., Ellingsen T., Hørslev-Petersen K., Hetland M.L., Junker P., Krogh N.S., Østergaard M., Stengaard-Pedersen K. M-ficolin levels reflect disease activity and predict remission in early rheumatoid arthritis. Arthritis Rheum. 2013, 65:3045-3050. 10.1002/art.38179.
2. Andersen T., Munthe-Fog L., Garred P., Jacobsen S. Serum levels of ficolin-3 (Hakata antigen) in patients with systemic lupus erythematosus. J. Rheumatol. 2009, 36:757-759. 10.3899/jrheum.080361.
3. Bombardier C., Gladman D.D., Urowitz M.B., Caron D., Chang C.H., Austin A., Bell A., Bloch D.A., Corey P.N., Decker J.L., Esdaile J., Fries J.F., Ginzler E.M., Goldsmith C.H., Hochberg M.C., Jones J.V., Riche N.G.H.Le., Liang M.H., Lockshin M.D., Muenz L.R., Sackett D.L., Schur P.H. Derivation of the sledai. A disease activity index for lupus patients. Arthritis Rheum. 1992, 35:630-640. 10.1002/art.1780350606.
4. Botto M., Dell'Agnola C., Bygrave A.E., Thompson E.M., Cook H.T., Petry F., Loos M., Pandolfi P.P., Walport M.J. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 1998, 19:56-59. 10.1038/ng0598-56.
5. Brady A.M., Spencer B.L., Falsey A.R., Nahm M.H. Blood collection tubes influence serum ficolin-1 and ficolin-2 levels. Clin. Vaccine Immunol. 2014, 21:51-55. 10.1128/CVI. 00607-13.
6. Gaitonde S., Samols D., Kushner I. C-reactive protein and systemic lupus erythematosus. Arthritis Rheum. 2008, 59:1814-1820. 10.1002/art.24316.
7. Garlatti V., Martin L., Lacroix M., Gout E., Arlaud G.J., Thielens N.M., Gaboriaud C. Structural insights into the recognition properties of human ficolins. J. Innate Immun. 2010, 2:17-23. 10.1159/000233475.
8. Gladman D., Ginzler E., Goldsmith C., Fortin P., Liang M., Urowitz M., Bacon P., Bombardieri S., Hanly J., Hay E., Isenberg D., Jones J., Kalunian K., Maddison P., Nived O., Petri M., Richter M., Sanchez-Guerrero J., Snaith M., Sturfelt G., Symmons D., Zoma a. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum. 1996, 39:363-369.
9. Hein E., Bay J.T., Munthe-Fog L., Garred P. Ficolin-2 reveals different analytical and biological properties dependent on different sample handling procedures. Mol. Immunol. 2013, 56:406-412. 10.1016/j.molimm.2013.05.233.
10. Hein E., Honoré C., Skjoedt M.-O., Munthe-Fog L., Hummelshøj T., Garred P. Functional analysis of Ficolin-3 mediated complement activation. PLoS One 2010, 5:e15443. 10.1371/journal.pone.0015443.
11. Hochberg M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997, 40:1725. 10.1002/1529-0131(199709)40:91725:AID-ART293.0.CO;2-Y.
12. Honoré C., Hummelshoj T., Hansen B.E., Madsen H.O., Eggleton P., Garred P. The innate immune component ficolin 3 (Hakata antigen) mediates the clearance of late apoptotic cells. Arthritis Rheum. 2007, 56:1598-1607. 10.1002/art.22564.
13. Honoré C., Rørvig S., Hummelshøj T., Skjoedt M.-O., Borregaard N., Garred P. Tethering of Ficolin-1 to cell surfaces through recognition of sialic acid by the fibrinogen-like domain. J. Leukoc. Biol. 2010, 88:145-158. 10.1189/jlb.1209802.
14. Hummelshoj T., Fog L.M., Madsen H.O., Sim R.B., Garred P. Comparative study of the human ficolins reveals unique features of Ficolin-3 (Hakata antigen). Mol. Immunol. 2008, 45:1623-1632. 10.1016/j.molimm.2007.10.006.
15. Inaba S., Okochi K., Yae Y., Niklasson F., de Verder C.H. Serological studies of an SLE-associated antigen-antibody system discovered as a precipitation reaction in agarose gel: the HAKATA antigen-antibody system. Fukuoka Igaku Zasshi 1990, 81:284-291.
16. Jensen M.L., Honoré C., Hummelshøj T., Hansen B.E., Madsen H.O., Garred P. Ficolin-2 recognizes DNA and participates in the clearance of dying host cells. Mol. Immunol. 2007, 44:856-865. 10.1016/j.molimm.2006.04.002.
17. Korb L.C., Ahearn J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 1997, 158:4525-4528.
18. Ma Y.J., Doni A., Romani L., Jürgensen H.J., Behrendt N., Mantovani A., Garred P. Ficolin-1-PTX3 complex formation promotes clearance of altered self-cells and modulates IL-8 production. J. Immunol. 2013, 191:1324-1333. 10.4049/jimmunol.1300382.
19. Ma Y.J., Skjoedt M.-O., Garred P. Collectin-11/MASP complex formation triggers activation of the lectin complement pathway-the fifth lectin pathway initiation complex. J. Innate Immun. 2013, 5:242-250. 10.1159/000345356.
20. Mevorach D., Mascarenhas J.O., Gershov D., Elkon K.B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 1998, 188:2313-2320.
21. Munthe-Fog L., Hummelshoj T., Honoré C., Moller M.E., Skjoedt M.O., Palsgaard I., Borregaard N., Madsen H.O., Garred P. Variation in FCN1 affects biosynthesis of ficolin-1 and is associated with outcome of systemic inflammation. Genes Immun. 2012, 1-8. 10.1038/gene.2012.27.
22. Munthe-Fog L., Hummelshøj T., Hansen B.E., Koch C., Madsen H.O., Skjødt K., Garred P. The impact of FCN2 polymorphisms and haplotypes on the Ficolin-2 serum levels. Scand. J. Immunol. 2007, 65:383-392. 10.1111/j. 1365-3083.2007.01915.x.
23. Munthe-Fog L., Hummelshøj T., Ma Y.J., Hansen B.E., Koch C., Madsen H.O., Skjødt K., Garred P. Characterization of a polymorphism in the coding sequence of FCN3 resulting in a Ficolin-3 (Hakata antigen) deficiency state. Mol. Immunol. 2008, 45:2660-2666. 10.1016/j.molimm.2007.12.012.
24. Nauta A.J., Raaschou-Jensen N., Roos A., Daha M.R., Madsen H.O., Borrias-Essers M.C., Ryder L.P., Koch C., Garred P. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur. J. Immunol. 2003, 33:2853-2863. 10.1002/eji.200323888.
25. Nielsen C.T., Østergaard O., Johnsen C., Jacobsen S., Heegaard N.H.H. Distinct features of circulating microparticles and their relationship to clinical manifestations in systemic lupus erythematosus. Arthritis Rheum. 2011, 63:3067-3077. 10.1002/art.30499.
26. Nisihara R.M., Magrini F., Mocelin V., Messias-Reason I.J. Deposition of the lectin pathway of complement in renal biopsies of lupus nephritis patients. Hum. Immunol. 2013, 74:907-910. 10.1016/j.humimm.2013.04.030.
27. Ogden C.a., deCathelineau a., Hoffmann P.R., Bratton D., Ghebrehiwet B., Fadok V.a., Henson P.M. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 2001, 194:781-795.
28. Østergaard O., Nielsen C.T., Iversen L.V., Tanassi J.T., Knudsen S., Jacobsen S., Heegaard N.H. Unique protein signature ofcirculating microparticles in systemic lupus erythematosus. Arthritis Rheum 2013, 65:2680-2690. 10.1002/art 38065.
29. Petri M., Kim M.Y., Kalunian K.C., Grossman J., Hahn B.H., Sammaritano L.R., Lockshin M., Merrill J.T., Belmont H.M., Askanase A.D., McCune W.J., Hearth-Holmes M., Dooley M.A., Von Feldt J., Friedman A., Tan M., Davis J., Cronin M., Diamond B., Mackay M., Sigler L., Fillius M., Rupel A., Licciardi F., Buyon J.P. Combined oral contraceptives in women with systemic lupus erythematosus. N. Engl. J. Med. 2005, 353:2550-2558. 10.1056/NEJMoa051135.
30. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11:785-797. 10.1038/ni.1923.
31. Rørvig S., Honore C., Larsson L.-I., Ohlsson S., Pedersen C.C., Jacobsen L.C., Cowland J.B., Garred P., Borregaard N. Ficolin-1 is present in a highly mobilizable subset of human neutrophil granules and associates with the cell surface after stimulation with fMLP. J. Leukoc. Biol. 2009, 86:1439-1449. 10.1189/jlb.1008606.
32. Stoll T., Seifert B., Isenberg D.A. SLICC/ACR Damage Index is valid, and renal and pulmonary organ scores are predictors of severe outcome in patients with systemic lupus erythematosus. Br. J. Rheumatol. 1996, 35:248-254.
33. Sugimoto R., Yae Y., Akaiwa M., Kitajima S., Shibata Y., Sato H., Hirata J., Okochi K., Izuhara K., Hamasaki N. Cloning and characterization of the Hakata antigen, a member of the ficolin/opsonin p35 lectin family. J. Biol. Chem. 1998, 273:20721-20727.
34. Thiel S. Complement activating soluble pattern recognition molecules with collagen-like regions, mannan-binding lectin, ficolins and associated proteins. Mol. Immunol. 2007, 44:3875-3888. 10.1016/j.molimm.2007.06.005.
35. Vander Cruyssen B., Nuytinck L., Boullart L., Elewaut D., Waegeman W., Van Thielen M., De Meester E., Lebeer K., Rossau R., De Keyser F. Polymorphisms in the ficolin 1 gene (FCN1) are associated with susceptibility to the development of rheumatoid arthritis. Rheumatology (Oxford) 2007, 46:1792-1795. 10.1093/rheumatology/kem266.
36. Walport M.J. Complement. Second of two parts. N. Engl. J. Med. 2001, 344:1140-1144. 10.1056/NEJM200104053441406.
37. Watanabe H., Saito R., Asano T., Sato S., Iwadate H., Kobayashi H., Ohira H. Serum L-ficolin levels in patients with systemic lupus erythematosus. Mod. Rheumatol. 2012, 12-15. 10.1007/s10165-012-0616-y.